| scholarly article | Q13442814 |
| P2093 | author name string | Salma K Jabbour | |
| Charles R Thomas | |||
| P2860 | cites work | Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis | Q24797571 |
| Cancer statistics, 2010 | Q27860525 | ||
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | Q29619394 | ||
| Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma | Q32033905 | ||
| The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma | Q34286442 | ||
| A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer | Q34593949 | ||
| A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer | Q35143202 | ||
| Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis | Q35803550 | ||
| Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases | Q36105855 | ||
| Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy | Q36213998 | ||
| Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. | Q37449181 | ||
| Impact of postoperative radiation after esophagectomy for esophageal cancer | Q37653973 | ||
| Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction | Q40382655 | ||
| Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research | Q43436684 | ||
| Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial | Q44017893 | ||
| Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. | Q44022873 | ||
| Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma | Q44779545 | ||
| Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus | Q46412803 | ||
| Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial. | Q46675470 | ||
| Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. | Q53395748 | ||
| Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. | Q53491085 | ||
| Four-dimensional computed tomographic analysis of esophageal mobility during normal respiration. | Q53499765 | ||
| Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: A prospective randomized study | Q53644293 | ||
| Occult lymph node metastases as a predictor of tumor relapse in patients with node-negative esophageal carcinoma | Q57940524 | ||
| Adenocarcinoma of the Esophagogastric Junction: The Pattern of Metastatic Lymph Node Dissemination as a Rationale for Elective Lymphatic Target Volume Definition | Q58028769 | ||
| 7th Edition of the AJCC Cancer Staging Manual: Esophagus and Esophagogastric Junction | Q63546492 | ||
| Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus | Q68122887 | ||
| Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study | Q70554151 | ||
| A comparison of multimodal therapy and surgery for esophageal adenocarcinoma | Q71164736 | ||
| Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: an intergroup study | Q71975350 | ||
| A comparison of chemotherapy and radiotherapy as adjuvant treatment to surgery for esophageal carcinoma. Japanese Esophageal Oncology Group | Q72815042 | ||
| Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus | Q73502951 | ||
| Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma | Q79608292 | ||
| Do we need more trials of postoperative radiotherapy after esophagectomy? | Q79999412 | ||
| Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer | Q80807888 | ||
| Comparison of efficacy of regional and extensive clinical target volumes in postoperative radiotherapy for esophageal squamous cell carcinoma | Q81249475 | ||
| Characterization of pathologic complete response after preoperative chemoradiotherapy in carcinoma of the esophagus and outcome after pathologic complete response | Q81394686 | ||
| Histologic subtypes as determinants of outcome in esophageal carcinoma patients with pathologic complete response after preoperative chemoradiotherapy | Q81624678 | ||
| Determination of the irradiation field for clinical T1-T3N0M0 thoracic/abdominal esophageal cancer based on the postoperative pathological results | Q82769476 | ||
| Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? | Q83888985 | ||
| P433 | issue | 2 | |
| P921 | main subject | esophageal cancer | Q372701 |
| adaptive radiation therapy | Q180507 | ||
| P304 | page(s) | 102-111 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Journal of gastrointestinal oncology | Q26842467 |
| P1476 | title | Radiation therapy in the postoperative management of esophageal cancer | |
| P478 | volume | 1 |
| Q35667892 | A pilot study of nimotuzumab combined with cisplatin and 5-FU in patients with advanced esophageal squamous cell carcinoma |
| Q65002906 | Adjuvant radiotherapy in oesophageal cancer with positive circumferential resection margins-recurrence and survival outcomes. |
| Q47375813 | Beclin 1 expression is associated with the occurrence and development of esophageal squamous cell carcinoma |
| Q42053185 | Does postoperative radiation therapy benefit patients with esophageal cancer? |
| Q35667875 | Early enteral infusion of traditional Chinese medicine preparation can effectively promote the recovery of gastrointestinal function after esophageal cancer surgery |
| Q34049113 | Esophageal cancer management controversies: Radiation oncology point of view |
| Q42238015 | Esophageal cancer: Is preoperative chemoradiation the new standard? |
| Q36411683 | HtrA1 expression associated with the occurrence and development of esophageal cancer |
| Q37245924 | Role of postoperative radiotherapy for microscopic margin involvement in the squamous cell carcinoma of esophagus |
| Q90410331 | The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma |
Search more.